Drug intelligence / Profile preview

Huyang Yangkun Gailiangfang

Development stage: Preclinical
Lead developer: Guangzhou University of Chinese Medicine
Administration: Oral

Overview

Huyang Yangkun Gailiangfang (HYF) is a Traditional Chinese Medicine (TCM) formula primarily investigated for the treatment of Premature Ovarian Insufficiency (POI) and ovarian aging symptoms in perimenopausal women. Derived from the traditional Chinese medicine recipe Danggui Buxue Tang, this multi-ingredient herbal formulation aims to enhance ovarian function and delay reproductive aging. Its mechanism of action involves modulating several cellular pathways, including the Hippo-JAK2/STAT3 pathway, the P53-mitochondrial apoptosis signaling pathway, and the FTO/m6A-P53 pathway. HYF works by protecting ovarian granulosa cells from apoptosis, enhancing follicle development, and influencing hypothalamic GnRH/LH pulse release. The formula consists of Astragali Radix, Herba Epimedii, Dioscoreae Rhizoma, Semen Cuscutae, Rehmanniae Radix, Angelicae Sinensis Radix, and Glehniae Radix.

Other names: Huyang Yangkun Formula

Targets

JAK2 (Janus kinase 2)STAT3 (Signal Transducer and Activator of Transcription 3)TP53 (Cellular Tumor Antigen p53 R175H)FTO (Fat mass and obesity-associated protein)

Beyond the preview

Go deeper on Huyang Yangkun Gailiangfang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huyang Yangkun Gailiangfang.

Explore the full profile